SCHEMBL31236014

SCHEMBL31236014

COc1cc2c(cc1C(=O)N[C@H]1CCC(=O)NC1=O)C1(CCN(Cc3ccccc3)CC1)CO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 2/20 0.49
DRD4 P21917 12/20 0.46
DRD2 P14416 6/20 0.46
DRD3 P35462 5/20 0.46
CYP3A4 P08684 2/20 0.45
CYP1A2 P05177 1/20 0.45
ADRA2A P08913 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
ACHE P22303 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
ADRA1A P35348 1/20 0.45
OPRK1 P41145 1/20 0.45
HTR2B P41595 1/20 0.45
CHRNA4 P43681 1/20 0.45
HTR3A P46098 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31236086 0.83 CRBN (0.55) CRBNDDB1
SCHEMBL34460295 0.81 S1PR5 (0.46) DRD4DRD2DRD3
SCHEMBL31236031 0.81 S1PR5 (0.46) DRD4DRD2DRD3
SCHEMBL31235971 0.81 CCR8 (0.48) DRD4DRD2
SCHEMBL34460359 0.80 CRBN (0.55) CRBNDDB1
SCHEMBL25342485 0.75 S1PR5 (0.49) CYP2D6
SCHEMBL31024716 0.75 S1PR5 (0.49) CYP2D6
SCHEMBL31236079 0.73 SIGMAR1 (0.47) DRD4DRD2DRD3CYP3A4CYP1A2
SCHEMBL30743117 0.72 S1PR5 (0.51) CRBNDDB1
SCHEMBL30743113 0.72 S1PR5 (0.51) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722219-A1 CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION Gan & Lee Pharmaceuticals Co., Ltd. (CN) 2026-04-08 EP disclosed
WO-2024240268-A1 CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION 甘李药业股份有限公司 2024-11-28 WO disclosed